home / stock / sramf / sramf news
Sisram Medical press release ( OTCPK:SRAMF ): 1H Revenue of $174.5M (+39.3% Y/Y). Profit for the period attributable to owners of the parent company was $20.6M, an increase of 25.9% Y/Y. For further details see: Sisram Medical reports 1H results
On December 16, Fosun and BioNTech announced the formation of a strategic alliance for marketing BioNtech's Covid 19-vaccine in China, Hong Kong, Taiwan and Macao. Under the agreement, BioNTech has committed to supply at least 100 million doses to Fosun in 2021, with preparations repo...